SMMT

Summit Therapeutics Inc.

1SMMT
USA
NASDAQ

$7.78

24H

2.08%

Market Cap

5.5 B

Volume

1.8 M

Supply

702 M

Price Chart

About Summit Therapeutics Inc. - SMMT

Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines for diseases that have a significant unmet medical need, particularly in the area of antibacterial and antifungal drug development. Their work often involves targeting therapy areas such as infectious diseases caused by antibiotic-resistant bacteria.

What are Summit Therapeutics Inc.'s core values and mission statement?

Summit Therapeutics Inc.'s mission is centered on the discovery, development, and commercialization of novel medicines to treat diseases for which there are no existing or only inadequate therapies. Their core values emphasize innovation, collaboration, and the pursuit of excellence in creating therapies that improve patient outcomes.

Who founded Summit Therapeutics Inc. and when?

Summit Therapeutics Inc. was founded by Dr. Kay Davies and Steve Davies in 2003.

Who leads Summit Therapeutics Inc.?

As of the latest available information, Summit Therapeutics Inc. was being led by its CEO, Dr. Maky Zanganeh. Leadership roles, however, can change, so it's advisable to check the latest company reports or official announcements for the most current leadership information.

Where is Summit Therapeutics Inc. located, and what is its base country?

Summit Therapeutics Inc. is headquartered in Cambridge, Massachusetts, and its base country is the United States.

On which exchanges is Summit Therapeutics Inc. traded?

Summit Therapeutics Inc. is traded on the NASDAQ under the ticker symbol SMMT.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Summit Therapeutics Inc. (SMMT) Price Live Data

The live price of Summit Therapeutics Inc. (SMMT) is $7.78, with a trading volume of 1,830,342 in the last 24 hours. Wrapstocks updates the SMMT price in real-time. Summit Therapeutics Inc. is down -2.08% in the last 24 hours. The company has a live market cap of $5,457,894,912.00 and a supply of 701,980,053 SMMT stocks.

Summit Therapeutics Inc. (SMMT) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 55 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
7 hours and 55 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
20 Jun 2024 07:56 PM